Assessment of Normal Systolic Blood Pressure Maintenance with the Risk of Coronary Artery Calcification Progression in Asymptomatic Metabolically Healthy Korean Adults with Normal Weight, Overweight, and Obesity

Metabolically healthy obesity (MHO) is known to have a close association with subclinical coronary atherosclerosis. Despite recent data on the benefit of intensive systolic blood pressure (SBP) control in diverse clinical conditions, little is known regarding the association of normal SBP maintenance (SBPmaintain) with coronary artery calcification (CAC) progression in MHO. This study included 2724 asymptomatic adults (48.8 ± 7.8 years; 77.9% men) who had no metabolic abnormalities except overweight and obesity. Participants with normal weight (44.2%), overweight (31.6%), and obesity (24.2%) were divided into two groups: normal SBPmaintain (follow-up SBP < 120 mm Hg) and ≥elevated SBPmaintain (follow-up SBP ≥ 120 mm Hg). CAC progression was defined using the SQRT method, a difference of ≥2.5 between the square root (√) of the baseline and follow-up coronary artery calcium score. During a mean follow-up of 3.4 years, the proportion of normal SBPmaintain (76.2%, 65.2%, and 59.1%) and the incidence of CAC progression (15.0%, 21.3%, and 23.5%) was different in participants with normal weight, overweight, and obesity (all p < 0.05, respectively). The incidence of CAC progression was lower in the normal SBPmaintain group than in the ≥elevated SBPmaintain group in only participants with obesity (20.8% vs. 27.4%, p = 0.048). In multiple logistic models, compared to participants with normal weight, those with obesity had a higher risk of CAC progression. Normal SBPmaintain was independently associated with the decreased risk of CAC progression in participants with obesity. MHO had a significant association with CAC progression. Normal SBPmaintain reduced the risk of CAC progression in asymptomatic adults with MHO.

[1]  Jong Won Kim,et al.  Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity , 2023, Journal of obesity & metabolic syndrome.

[2]  N. Wong Evolution of Coronary Calcium Screening for Assessment of Atherosclerotic Cardiovascular Disease Risk and Role in Preventive Cardiology , 2022, Current atherosclerosis reports.

[3]  M. Gąsior,et al.  An update on the coronary calcium score: a review for clinicians , 2022, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

[4]  Jeroen J. Bax,et al.  Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease , 2022, Clinical cardiology.

[5]  Weili Zhang,et al.  Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. , 2021, The New England journal of medicine.

[6]  Jae Hyun Kim,et al.  2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea , 2021, Journal of obesity & metabolic syndrome.

[7]  J. Williamson,et al.  Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. , 2021, The New England journal of medicine.

[8]  Hyuk-Jae Chang,et al.  Sex differences in coronary artery calcium progression: The Korea Initiatives on Coronary Artery Calcification (KOICA) registry , 2021, PloS one.

[9]  W. Cushman,et al.  KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. , 2021, Kidney international.

[10]  G. Watts,et al.  Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease. , 2021, JACC. Cardiovascular imaging.

[11]  Emily C. O'Brien,et al.  Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. , 2020, JAMA cardiology.

[12]  T. Yeh,et al.  Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis , 2020, PeerJ.

[13]  D. Berman,et al.  Role of Coronary Artery Calcium for Stratifying Cardiovascular Risk in Adults With Hypertension: The Coronary Artery Calcium Consortium , 2019, Hypertension.

[14]  S. Moebus,et al.  Associations of metabolically healthy obesity with prevalence and progression of coronary artery calcification: Results from the Heinz Nixdorf Recall Cohort Study. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[15]  A. Aljizeeri,et al.  Coronary artery calcium score to guide hypertension therapy! , 2019, Atherosclerosis.

[16]  Jeroen J. Bax,et al.  Longitudinal quantitative assessment of coronary plaque progression related to body mass index using serial coronary computed tomography angiography. , 2019, European heart journal cardiovascular Imaging.

[17]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[18]  Jeroen J. Bax,et al.  Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study. , 2018, JACC. Cardiovascular imaging.

[19]  D. Berman,et al.  Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study , 2018, European heart journal.

[20]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[21]  S. Moebus,et al.  Value of Progression of Coronary Artery Calcification for Risk Prediction of Coronary and Cardiovascular Events , 2017, Circulation.

[22]  K. Toulis,et al.  Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women. , 2017, Journal of the American College of Cardiology.

[23]  L. Shaw,et al.  Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. , 2017, JACC. Cardiovascular imaging.

[24]  M. Budoff,et al.  Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy , 2017, Circulation.

[25]  Hyuk-Jae Chang,et al.  Reassessing the Usefulness of Coronary Artery Calcium Score among Varying Racial and Ethnic Groups by Geographic Locations: Relevance of the Korea Initiatives on Coronary Artery Calcification Registry , 2015, Journal of cardiovascular ultrasound.

[26]  J. Stevens,et al.  Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. , 2015, American journal of epidemiology.

[27]  J. Rey-Lopez,et al.  The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used , 2014, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[28]  J. Lima,et al.  Metabolically-healthy obesity and coronary artery calcification. , 2014, Journal of the American College of Cardiology.

[29]  David C. Wheeler,et al.  Notice , 2012, Kidney International Supplements.

[30]  Hyuk-Jae Chang,et al.  Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. , 2012, European heart journal.

[31]  Daniel S Berman,et al.  Progression of coronary artery calcium predicts all-cause mortality. , 2010, JACC. Cardiovascular imaging.

[32]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[33]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[34]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[35]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[36]  M. Budoff,et al.  Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi-Ethnic Study of Atherosclerosis. , 2009, AJR. American journal of roentgenology.

[37]  W. Kalender,et al.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging , 2008, European Radiology.

[38]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[39]  R. Eckel,et al.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.

[40]  Richard D. White,et al.  Potential clinical impact of variability in the measurement of coronary artery calcification with sequential MDCT. , 2005, AJR. American journal of roentgenology.

[41]  Dana Dabelea,et al.  Evaluating changes in coronary artery calcium: an analytic method that accounts for interscan variability. , 2004, AJR. American journal of roentgenology.

[42]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[43]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[44]  P. Wilson,et al.  Overweight and Obesity as Determinants of Cardiovascular Risk , 2017 .